CytoDyn Inc.
13 private offerings reported to the SEC on Form D since 2016, $108.1M sold in all. Pharma, Washington.
- Form D offerings: 13
- Reported sold: $108.1M
- Newest: May 11, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| May 11, 2026 | — | $18.6M | $18.6M | CytoDyn Inc.Pharma · Washington | Not amended | 0001175680-26-000003 |
| Apr 22, 2022 | — | $21.8M | $21.8M | CytoDyn Inc.Pharma · Washington | Sep 19, 2022 | 0001209191-22-025264 |
| Dec 3, 2021 | — | $11.4M | $53.6M | CytoDyn Inc.Biotech · Washington | Not amended | 0001209191-21-067720 |
| Sep 16, 2021 | — | $2.9M | $25.2M | CytoDyn Inc.Biotech · Washington | Not amended | 0001209191-21-056309 |
| Dec 16, 2020 | — | $1.0M | $1.0M | CytoDyn Inc.Biotech · Washington | Not amended | 0001807094-20-000027 |
| Dec 16, 2020 | — | None yet | $1.2M | CytoDyn Inc.Biotech · Washington | Not amended | 0001807094-20-000028 |
| Mar 30, 2020 | — | $882K | $1.2M | CytoDyn Inc.Biotech · Washington | Not amended | 0001807094-20-000003 |
| Feb 14, 2020 | — | $7.6M | $11.4M | CytoDyn Inc.Biotech · Washington | Apr 7, 2020 | 0001209191-20-009437 |
| Apr 2, 2019 | — | $7.8M | $20.0M | CytoDyn Inc.Biotech · Washington | Nov 12, 2019 | 0000905718-19-000315 |
| Sep 10, 2018 | — | $13.2M | $25.0M | CytoDyn Inc.Biotech · Washington | Not amended | 0000905718-18-000786 |
| Nov 16, 2017 | — | $17.6M | $17.6M | CytoDyn Inc.Biotech · Washington | Feb 28, 2018 | 0000905718-17-000980 |
| Jun 14, 2017 | — | $1.1M | $15.0M | CytoDyn Inc.Biotech · Washington | Not amended | 0000905718-17-000598 |
| May 11, 2016 | — | $4.3M | $10.0M | CytoDyn Inc.Biotech · Washington | Not amended | 0000905718-16-001389 |
- Ticker
- CYDY
- Business address
- Vancouver, Wa
- Incorporated in
- Delaware
- SEC industry
- Pharmaceutical Preparations
- Former names
- Cytodyn Inc; Rexray Corp
- All SEC filings
- CIK 1175680 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR